Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury
Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury
Not yet recruiting · NCT07861126 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury | Brain Injuries, Traumatic, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Not yet recruiting | Phase 3 | 2026-10-06 | NCT07861126 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pharmazz, Inc. | 8 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||